Description
This variant is denoted SMAD4 c.799A>C at the cDNA level, p.Thr267Pro (T267P) at the protein level, and results in the change of a Threonine to a Proline (ACC>CCC). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. SMAD4 Thr267Pro was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Since Threonine and Proline differ in polarity, charge, size or other properties, this is considered a non-conservative amino acid substitution. SMAD4 Thr267Pro occurs at a position where amino acids with properties similar to Threonine are tolerated across species and is not located in a known functional domain (Uniprot). In silico analyses are inconsistent regarding the effect this variant may have on protein structure and function. Based on currently available information, it is unclear whether SMAD4 Thr267Pro is pathogenic or benign. We consider it to be a variant of uncertain significance.
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | germline | yes | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |